Discover the 4 key reasons why, despite enjoying NixOS, I'm now searching for alternatives due to its steep learning curve, user experience, software installation challenges, and hardware ...

Recursion Pharmaceuticals (RXRX) closed at $4.77 in the latest trading session, marking a -1.24% move from the prior day. This change lagged the S&P 500's 0.47% gain on the day. Meanwhile, the Dow ...

The rate of acquisition of genomic changes in cancer has been the topic of much discussion, with several recent investigations finding evidence of punctuated evolution instead of gradual accumulation ...

4 analysts have expressed a variety of opinions on Recursion Pharmaceuticals (NASDAQ:RXRX) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Welcome to this afternoon session with Recursion. My name is Andrew Pucher. I'm part of the Healthcare Investment Banking team, and I'm joined by Ben Taylor, CFO of Recursion; and Sara Sherman, Head ...

A maker mapped neural inference into Minecraft’s redstone circuits, creating a 5-million-parameter “ChatGPT” in a sandbox ...

Scientists have unlocked the mystery of how Burmese pythons digest bones without leaving any trace in their droppings. The secret lies in specialized intestinal cells that collect excess calcium and ...

John Cleese comes on the line to chat about his Not Dead Yet! tour, which comes to Southern California to celebrate the 50th anniversary of “Monty Python and Holy Grail,” but before we can ask our ...